Abstract

From the gynecologic point of view ocular metastases are uncommon and mostly unknown, while malignancies of the breast are the most common primary tumor when metastases are found in the eye. Even more unknown is the fact that in 3% of breast cancer cases the first clinical manifestation is a tumor in the eye [1]. We describe the case of a 64-year-old woman who has been treated by her ophthalmologists for increasing motility disorders of the eye. The woman had a known endocrinologic orbitopathy. The worsening of her symptoms was at first associated with the endocrinologic orbitopathy. But the initiated corticoid treatment did not improve the symptoms: they even worsened. Subsequently further diagnostic tests were done in the course of which a retrobulbar tumor was diagnosed. The histology suggested the primary tumor was breast cancer. The described procedures took one year, after which the woman was referred to the gynaecological department, where a mammography led to the final diagnosis of breast cancer. Due to the high incidence of breast cancer the total number of women who first see an ophthalmologist for vision problems caused by a tumor in the eye is not negligible. This shows that both sides - the gynecologists and ophthalmologists - should be sensitised to the fact that the primary ofany tumor of the eye can be breast cancer, in order to direct treatment more quickly to the cause of the cancer, thus leading to a better curative success.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.